Pharmaceutical Regulatory Compliance UK - Trusted Expertise
Excellence in Pharmaceutical Integrity
Star Life Sciences Group is a regulated UK-based pharmaceutical holding company specialising in medical cannabis and advanced therapeutics. We maintain a steadfast commitment to robust corporate governance, ethical clinical practice, and the highest standards of patient safety.
International Standards & Local Oversight
Our operations are strictly governed by key UK and international regulatory regimes, including MHRA (WDA) standards and Home Office licensing requirements.
These GDP and GMP principles are deeply embedded into our group policies, serving as the foundation for our operational controls and rigorous internal audit schedules. This ensures every stage of our supply chain meets pharmaceutical-grade integrity.
Certifications & Audits
Star Life Sciences Group maintains a robust framework of clinical verification and regulatory oversight. Our adherence to pharmaceutical excellence is validated through rigorous external audits and the maintenance of essential licenses for the distribution and manufacture of advanced therapeutics.
WDA & GMP Licenses
- MHRA Wholesale Distribution Authorisation (WDA) holding for pharmaceutical products.
- Adherence to EU Good Manufacturing Practice (GMP) for secure therapeutic fabrication.
- Home Office licenses for the handling and distribution of medical cannabis.
Third-Party Audits
- Independent annual governance reviews conducted by Tier-1 regulatory consultancies.
- Routine Home Office and external compliance inspections to maintain group-wide integrity.
- Strict third-party supply chain verification protocols to ensure clinical safety.
Internal QA Systems
- Real-time track-and-trace systems embedded within the medical cannabis holding chain.
- Automated SOP control loops to prevent governance lapses in pharmaceutical logistics.
- Continuous internal quality control monitoring for patient safety and product efficacy.